Browse by article | Browse by volume |
If you want to download the article, please login or register as reader.
Heroin Addiction and Related Clinical Problems: 2019, 21, N1 (pages: 5 - 10) Improving Response Capacities in Opioid Overdose Management Cozzolino E., D'Egidio P.F., De Facci R., Leonardi C., Nava F., Stella L., and Maremmani I. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N1 (pages: 15 - 20) Jan S.U.K., and Ali A. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N1 (pages: 21 - 28) Heidebrecht F., and Macleod M.B. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N1 (pages: 29 - 34) Early Maladjustment Schemas in Opioid Abstainers, Opioid Abusers and Normal Individuals Veiskarami H.A., Mirdrikvand F., Khodarahimi S., and Rahmian Bougar M. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N1 (pages: 35 - 45) Crowley D., Cullen W., Lambert J., and Van Hout M.C. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N1 (pages: 47 - 56) How to Improve a Poorly Running Agonist Opioid Treatment (Aot). Part 6: psychosocial Care Ulmer A., and Meinhold C. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N2 (pages: 5 - 19) Crowley D., Cullen W., Lambert J., and Van Hout M.C. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N2 (pages: 21 - 26) Over the Counter (Otc) Analgesic Misuse: One Patient's Journey Hill D., and Stewart E. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N2 (pages: 27 - 32) Kastelic A., Pregelj P., Zaman R., and Segrec N. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N2 (pages: 33 - 40) Alaei A., Mishkin K., Alaei K., Bilici R., Altintas M., and Altice F. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N2 (pages: 41 - 46) Surviving in the Workplace: Conditions in Centres for the Prevention and Treatment of Drug Addiction Ignjatova L. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N2 (pages: 47 - 52) Does Impulsivity Increase the Risk of Developing a Pathological Condition? Conversano C., Marchi L., Ciacchini R., Bertolucci I., Micheloni T., and Maremmani A.G.I. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N3 (pages: 7 - 16) Alnıak İ., Karabulut V., Evren C., Çetin T., Umut G., Ağaçhanlı R., and Evren B. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N3 (pages: 17 - 26) Carlsen S.-E.L., and Torsheim T. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N3 (pages: 27 - 35) Parrino M. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N3 (pages: 37 - 45) Claman A., Adelson M., Sason A., Barkay G., and Peles E. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N3 (pages: 47 - 51) Palma-Alvarez R.F., Ros-Cucurull E., Grau-López L., Martínez-Luna N., Rodríguez-Cintas L., Álvarez A.I., and Roncero C. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N3 (pages: 51 - 59) Rugani F., Paganin W., Maremmani A.G.I., Perugi G., and Maremmani I. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N4 (pages: 5 - 14) Association of Drd2 Gene Polymorphism with Heroin Dependence. Koijam A.S., and Haobam R. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N4 (pages: 15 - 22) Dişsiz M. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N4 (pages: 23 - 26) Risk of Hepatitis C Virus Infection among Heroin and Methamphetamine Users Okruhlica L., and Kamendy Z. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N4 (pages: 27 - 34) Olioff J., O Shea T., Horan A., Naughton A.M., and O'Brien D. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N4 (pages: 35 - 39) Maremmani A.G.I., Lovrecic M., Lovrecic B., and Maremmani I. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N4 (pages: 41 - 44) Muller A.E., and Roessler K.K. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N5 (pages: 5 - 6) The European Medical Agency and the Unfolding Destiny of Alcohol Use Disorder Patients Maremmani I. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N5 (pages: 7 - 12) Toward Diagnostic and Therapeutic Relativism in Psychiatry and Addiction Medicine Mendelevich V. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N5 (pages: 13 - 30) Mohd Fahami N.A., Nazrun Shuid A., Abdullah A., Naina-Mohamed I., Chin K.-Y., Mohamed N., Masbah N., Haji Mohd Saad Q., Kamisah Y., and Muhammad N. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N5 (pages: 33 - 40) Sarami Foroushani N. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N5 (pages: 41 - 53) Cardiological Safety in Patients Receiving Methadone Treatment Farina G., Mungai F., and Starace F. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N5 (pages: 51 - 58) Asan Ö., Şahiner İ.V., Şahiner Ş.Y., and Göka E. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N5 (pages: 61 - 66) Carbone M.G., Tagliarini C., Ricci M., Lupi A.M., Sarandrea L., Ceban A., Casella P., and Maremmani I. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N6 (pages: 5 - 16) Bronzina V., Conversano C., Maremmani A.G.I., Lamanna F., Pacini M., and Maremmani I. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N6 (pages: 17 - 19) Intravenous Abuse of Naphazoline and Heroin Mixture, a Case Report Kordrostami R., Akhgari M., and Ameri M. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N6 (pages: 21 - 29) Pérez V., Hidalgo M.J., Martínez M., Orozco D., and Girón M. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N6 (pages: 31 - 36) A Clinical Case Control Study to Evaluate Oxidative Stress in Heroin Addicts Ullah A., Khan A., Iqbal Z., Khan I., Ahmad L., Kaleem W.A., Alam M., Ullah N., and Ahmad M. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N6 (pages: 37 - 44) Simonovska N., and Zafirova-Ivanovska B. |
Heroin Addiction and Related Clinical Problems: 2019, 21, N6 (pages: 45 - 47) Avoiding the “Wrong Door Syndrome”. The Experience of Dual Disorder Unit in Catanzaro, Italy, Eu Insardà A. |
EUROPAD - European Opiate Addiction Treatment Association Rolex replica
Brussels, Belgium, EU P. IVA 01681650469 – Codice Fiscale 94002580465 Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org |